|
|
|
Insider
Information: |
Mueller Peter |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
311,837 |
|
Indirect Shares
|
25,571 |
|
|
Direct
Value |
$68,363,700 |
|
|
Indirect Value
|
$12,144,946 |
|
|
Total
Shares |
337,408 |
|
|
Total
Value |
$80,508,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global R&D, CSO |
2014-06-16 |
143,517 |
2014-06-16 |
25,571 |
Premium* |
|
Bioxcel Therapeutics Inc |
BTAI |
Director |
2019-08-23 |
168,320 |
2018-12-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-02-18 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
166,250 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-03-17 |
4 |
AS |
$78.19 |
$587,145 |
D/D |
(7,500) |
158,750 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-03-17 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
166,250 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-04-15 |
4 |
OE |
$28.84 |
$235,390 |
D/D |
7,500 |
166,250 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-04-15 |
4 |
AS |
$60.57 |
$462,207 |
D/D |
(7,500) |
158,750 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-05-14 |
4 |
OE |
$32.16 |
$241,200 |
D/D |
7,500 |
151,017 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-05-14 |
4 |
AS |
$66.13 |
$505,849 |
D/D |
(7,500) |
143,517 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-06-16 |
4 |
OE |
$32.16 |
$241,200 |
D/D |
7,500 |
151,017 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2014-06-16 |
4 |
AS |
$67.72 |
$512,352 |
D/D |
(7,500) |
143,517 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-08-29 |
4 |
AS |
$45.01 |
$427,595 |
D/D |
(9,500) |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-08-29 |
4 |
OE |
$10.41 |
$103,367 |
D/D |
9,500 |
143,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-15 |
4 |
AS |
$50.03 |
$476,848 |
D/D |
(9,500) |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-15 |
4 |
OE |
$11.27 |
$107,065 |
D/D |
9,500 |
143,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-05-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,352 |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
|
2007-05-07 |
4 |
AS |
$30.59 |
$348,757 |
D/D |
(11,401) |
73,430 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2009-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
97,356 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
144,400 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2006-02-02 |
4 |
A |
$0.01 |
$122 |
D/D |
12,200 |
85,531 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-04-25 |
4 |
AS |
$50.00 |
$625,000 |
D/D |
(12,500) |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-04-25 |
4 |
OE |
$16.32 |
$204,000 |
D/D |
12,500 |
146,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2009-05-07 |
4 |
AS |
$28.94 |
$370,316 |
D/D |
(12,796) |
116,796 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-02-07 |
4 |
A |
$0.01 |
$145 |
D/D |
14,501 |
87,931 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2010-02-04 |
4 |
A |
$0.01 |
$145 |
D/D |
14,501 |
125,505 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-02-03 |
4 |
A |
$0.01 |
$145 |
D/D |
14,501 |
133,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-02-02 |
4 |
A |
$0.01 |
$145 |
D/D |
14,501 |
148,236 |
0 |
- |
|
141 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|